News & Updates

Dry powder for inhalation 100 mcg/62.5 mcg/25 mcg

In the first-line treatment of patients with EGFR-mutated locally advanced or metastatic non–small-cell lung cancer (NSCLC), the novel third-generation EGFR tyrosine kinase inhibitor rezivertinib yields superior overall efficacy and progression-free survival (PFS) when compared with gefitinib, with no new safety signals, according to the phase III REZOR trial.

All biologic classes—anti-IgE, anti-IL5/R, and anti-IL4R—help improve outcomes in patients with severe allergic asthma with nasal polyps treated in real-world settings, according to a study. However, anti-IL4R bests the other two in terms of improving the smell, nasal obstruction, and nasal polyp endoscopic size.

The likelihood of extubation failure in preterm neonates is high among those with lower gestational and chronological age and higher levels of pre-extubation ventilation support, according to the results of a systematic review and meta-analysis.

The use of montelukast in children treated in routine practice does not appear to pose any risks of neuropsychiatric events such as anxiety, depression, and sleep-related disorders, among others.

Replacing saturated fatty acid (SFA) with unsaturated fatty acids, particularly from plant sources, and eliminating dietary trans fatty acid (TFA) can help prevent premature death, according to a study.